Menadione sodium bisulfite (Vikasol) intramuscular injections 1% 1 ml – [10 ampoules]

Description Vicasol PharmacodynamicsAntihemorrhagic agent. It is a synthetic analogue of vitamin K. It is a cofactor of synthesis of prothrombin and other factors of blood coagulation (VII, IX, X) in the liver, helps to normalize blood clotting. IndicationsHemorrhagic syndrome, associated with hypoprothrombinemia; hypovitaminosis K (including obstructive jaundice, hepatitis, cirrhosis, prolonged diarrhea); hemorrhagic disease in newborns, bleeding after injuries, trauma and surgery, in gynecology, as part of the complex treatment of dysfunctional uterine bleeding, unrelated to organic pathology, with menorrhagia. As a specific antagonist for bleeding associated with taking indirect anticoagulants. III trimester of pregnancy (to prevent bleeding in newborns. Contraindications .Increased blood clotting, thromboembolism, hypersensitivity to menadione. Dosage and administration The drug is administered intramuscularly. For adults: single dose – 10-15 mg, maximum single dose – 30 mg, maximum daily dose – 60 mg. In pediatrics:.To newborns – up to 4 mg/day;Up to 1 year old – 2-5 mg/day;1 -2 years – 6 mg/day;3-4 years – 8 mg/day;5-9 years old – 10 mg/day;10-14 years old – 15 mg/day. From the age of 15 years, the drug is prescribed in the same way as in adult patients. Treatment duration is 3-4 days, after a 4-day break the course is repeated if necessary. The daily dose may be divided into 2-3 doses. During surgical interventions with possible severe parenchymal bleeding is prescribed for 2-3 days before surgery.